BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38368674)

  • 1. ZNF468 inhibits irradiation-induced G2/M cell cycle arrest and apoptosis by facilitating AURKA transcription in Esophageal Squamous Cell Carcinoma.
    Bai G; Mahati S; Tulahong A; Eli M; Mao R
    Biochem Biophys Res Commun; 2024 Apr; 703():149687. PubMed ID: 38368674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of SOCS6 confers radioresistance in esophageal squamous cell carcinoma.
    Ma R; Shi M; Hu J; Zhao LN
    Biochem Biophys Res Commun; 2021 Apr; 550():92-98. PubMed ID: 33689885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-4443 promotes radiation resistance of esophageal squamous cell carcinoma via targeting PTPRJ.
    Shi X; Liu X; Huang S; Hao Y; Pan S; Ke Y; Guo W; Wang Y; Ma H
    J Transl Med; 2022 Dec; 20(1):626. PubMed ID: 36578050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of microRNA-136 induces apoptosis and radiosensitivity of esophageal squamous cell carcinoma cells by inhibiting the expression of MUC1.
    Huang HZ; Yin YF; Wan WJ; Xia D; Wang R; Shen XM
    Exp Mol Pathol; 2019 Oct; 110():104278. PubMed ID: 31247211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of long non-coding RNA Rpph1 in esophageal cancer and its effect on cancer cell sensitivity to radiotherapy.
    Li ZY; Li HF; Zhang YY; Zhang XL; Wang B; Liu JT
    World J Gastroenterol; 2020 Apr; 26(15):1775-1791. PubMed ID: 32351293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cetuximab enhances radiosensitivity of esophageal squamous cell carcinoma cells by G2/M cycle arrest and DNA repair delay through inhibiting p-EGFR and p-ERK.
    Zhao G; Feng L; Ye T; Liu Y; Fan L; Ye C; Chen J
    Thorac Cancer; 2023 Aug; 14(22):2127-2138. PubMed ID: 37337933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation induces NORAD expression to promote ESCC radiotherapy resistance via EEPD1/ATR/Chk1 signalling and by inhibiting pri-miR-199a1 processing and the exosomal transfer of miR-199a-5p.
    Sun Y; Wang J; Ma Y; Li J; Sun X; Zhao X; Shi X; Hu Y; Qu F; Zhang X
    J Exp Clin Cancer Res; 2021 Sep; 40(1):306. PubMed ID: 34587992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An emerging biomarker for the diagnosis and treatment of esophageal squamous cell carcinoma - Aurora A.
    Zhou W; Guo S; Zhang J; Yan Y; Wu J; Liu X
    Comput Biol Med; 2024 Jan; 168():107759. PubMed ID: 38043467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ATPase subunit of ATP6V1C1 inhibits autophagy and enhances radiotherapy resistance in esophageal squamous cell carcinoma.
    Yao X; Chen H; Xu B; Lu J; Gu J; Chen F; Ju M; Sun X
    Gene; 2021 Feb; 768():145261. PubMed ID: 33183740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USP8 inhibitor-induced DNA damage activates cell cycle arrest, apoptosis, and autophagy in esophageal squamous cell carcinoma.
    Sha B; Sun Y; Zhao S; Li M; Huang W; Li Z; Shi J; Han X; Li P; Hu T; Chen P
    Cell Biol Toxicol; 2023 Oct; 39(5):2011-2032. PubMed ID: 35022897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics and experimental validation of an AURKA/TPX2 axis as a potential target in esophageal squamous cell carcinoma.
    Du R; Li K; Zhou Z; Huang Y; Guo K; Zhang H; Chen Z; Zhao X; Han L; Bian H
    Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37083097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-29b regulates the radiosensitivity of esophageal squamous cell carcinoma by regulating the BTG2-mediated cell cycle.
    Guo D; Jin J; Liu J; Dong X; Li D; He Y
    Strahlenther Onkol; 2021 Sep; 197(9):829-835. PubMed ID: 34232332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD59 is a potential biomarker of esophageal squamous cell carcinoma radioresistance by affecting DNA repair.
    Zhou Y; Chu L; Wang Q; Dai W; Zhang X; Chen J; Li L; Ding P; Zhang L; Gu H; Li L; Lv X; Zhang W; Zhou D; Zhang P; Cai G; Zhao K; Hu W
    Cell Death Dis; 2018 Aug; 9(9):887. PubMed ID: 30166523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway.
    Zhang Y; Chen W; Wang H; Pan T; Zhang Y; Li C
    Cancer Chemother Pharmacol; 2019 Dec; 84(6):1209-1218. PubMed ID: 31529206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression.
    Zhang X; Yang X; Zhu S; Li Q; Zou N
    Oncol Rep; 2019 Mar; 41(3):1960-1970. PubMed ID: 30569171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET.
    Wang P; Yang Z; Ye T; Shao F; Li J; Sun N; He J
    J Exp Clin Cancer Res; 2020 Jan; 39(1):7. PubMed ID: 31918742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway.
    Yang XX; Ma M; Sang MX; Zhang XY; Liu ZK; Song H; Zhu SC
    Oncol Rep; 2018 Feb; 39(2):667-678. PubMed ID: 29207170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo.
    Li H; Juan L; Xia L; Wang Y; Bao Y; Sun G
    Med Sci Monit; 2016 Jul; 22():2624-34. PubMed ID: 27453171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evodiamine inhibits ESCC by inducing M-phase cell-cycle arrest via CUL4A/p53/p21 axis and activating noxa-dependent intrinsic and DR4-dependent extrinsic apoptosis.
    Zhang L; Li L; Chen X; Yuan S; Xu T; Zhao W; Li M; Wang F; Hoffman RM; Jia L
    Phytomedicine; 2023 Jan; 108():154493. PubMed ID: 36265256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERK inhibitor: A candidate enhancing therapeutic effects of conventional chemo-radiotherapy in esophageal squamous cell carcinoma.
    Song Y; Cheng Y; Lan T; Bai Z; Liu Y; Bi Z; Alu A; Cheng D; Wei Y; Wei X
    Cancer Lett; 2023 Feb; 554():216012. PubMed ID: 36470544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.